Search

everythinglearnresearchcommunity

for

Search:↓

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Hormonal contraceptives and related compounds can increase health risks like thrombosis and affect sexual function.

Chemotherapy often causes skin and hair issues, but early management can help improve patient care.

Testosterone's health effects are complex and not definitively understood.

Natural compounds from Chinese herbs may safely promote hair growth and treat common hair loss.

PM-9 and finasteride effectively inhibit the enzyme that converts testosterone to DHT.

Organoids created from stem cells are used to model diseases, test drugs, and develop personalized and regenerative medicine.

Resveratrol shows health benefits but faces challenges in effectiveness and regulation.

Multitarget drugs are needed to better treat complex diseases.

5alpha-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT, offering symptom relief and potential future uses.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

3D-printed hydrogels show promise in medicine but face challenges in resolution, cell viability, cost, and regulations.

Guava leaf extract may help treat hair loss and protect cells by blocking certain genes and fighting damaging molecules.

Organoids can revolutionize medicine by modeling diseases and aiding in personalized treatments.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Larger prostate size in older men may be linked to poorer semen quality and fertility issues.

Bald men may have a lower risk of testicular cancer.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

Older adults have a high rate of skin cancers like basal cell carcinoma and melanoma, mainly due to UV exposure and age.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Men with male pattern baldness have a higher risk of certain skin cancers, especially on the scalp.